The World Health Organization (WHO) has prequalified the first self-test kit to detect the hepatitis C virus (HCV)…
Articles by Margarida Maia, PhD
Livmarli (maralixibat), an oral medication from Mirum Pharmaceuticals, is now approved in the European Union to treat progressive…
A type of cell death called ferroptosis contributes to metabolic dysfunction-associated steatotic liver disease (MASLD), a form of fatty…
Women who develop a subtype of intrahepatic cholestasis of pregnancy (ICP) marked by jaundice — a yellowing of the…
Nearly all children with Alagille syndrome who received Mirum Pharmaceuticals’ Livmarli (maralixibat) for seven years as part of…
One year of treatment with Viking Therapeutics’ candidate VK2809 safely and effectively reduces liver fat content, damage, and scarring…
The first patient has been enrolled in WIND-PSC, a global study to track the natural course of primary sclerosing…
Note: This story was updated July 9, 2024, to clarify Livmarli is approved in the U.S. for all PFIC forms,…
The HealthWell Foundation, a charity that helps people who can’t afford to pay their medical bills, has started a…
Two scores calculated from blood biomarkers can accurately discriminate between pregnant women with intrahepatic cholestasis of pregnancy (ICP) and…